Ultragenyx Pharmaceutical
RARE
RARE
172 hedge funds and large institutions have $2.49B invested in Ultragenyx Pharmaceutical in 2019 Q4 according to their latest regulatory filings, with 28 funds opening new positions, 71 increasing their positions, 48 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
0.94% less ownership
Funds ownership: 101.83% → 100.88% (-0.94%)
86% less call options, than puts
Call options by funds: $1.78M | Put options by funds: $12.3M
Holders
172
Holding in Top 10
1
Calls
$1.78M
Puts
$12.3M
Top Buyers
| 1 | +$45.3M | |
| 2 | +$37M | |
| 3 | +$9.62M | |
| 4 |
AllianceBernstein
Nashville,
Tennessee
|
+$9.04M |
| 5 |
EC
EcoR1 Capital
San Francisco,
California
|
+$8.54M |
Top Sellers
| 1 | -$84.4M | |
| 2 | -$38M | |
| 3 | -$35.7M | |
| 4 |
HCM
Highline Capital Management
New York
|
-$12.6M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$11.1M |